These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29477727)

  • 21. The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity.
    Harizi H
    Biomed Res Int; 2013; 2013():683405. PubMed ID: 24024207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotrienes: mediators that have been typecast as villains.
    Flamand N; Mancuso P; Serezani CH; Brock TG
    Cell Mol Life Sci; 2007 Oct; 64(19-20):2657-70. PubMed ID: 17639273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the function, development, and plasticity of type 2 innate lymphoid cells.
    Krabbendam L; Bal SM; Spits H; Golebski K
    Immunol Rev; 2018 Nov; 286(1):74-85. PubMed ID: 30294969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.
    Karta MR; Broide DH; Doherty TA
    Curr Allergy Asthma Rep; 2016 Jan; 16(1):8. PubMed ID: 26746844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Leukotrienes as inflammation mediators].
    Woszczek G; Pawliczak R; Kowalski ML
    Postepy Hig Med Dosw; 2003; 57(5):593-610. PubMed ID: 14737972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukotrienes orchestrating allergic skin inflammation.
    Sadik CD; Sezin T; Kim ND
    Exp Dermatol; 2013 Nov; 22(11):705-9. PubMed ID: 24433180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
    Liu T; Kanaoka Y; Barrett NA; Feng C; Garofalo D; Lai J; Buchheit K; Bhattacharya N; Laidlaw TM; Katz HR; Boyce JA
    J Immunol; 2015 Oct; 195(8):3537-45. PubMed ID: 26342029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR; Ayars AG; Altman MC; Henderson WR
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate immunity as the orchestrator of allergic airway inflammation and resolution in asthma.
    Thiriou D; Morianos I; Xanthou G; Samitas K
    Int Immunopharmacol; 2017 Jul; 48():43-54. PubMed ID: 28463786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of eicosanoids as mediators of glomerular injury in immune-mediated nephropathies.
    Zoja C; Benigni A; Remuzzi G
    Contrib Nephrol; 1989; 69():18-26; discussion 37-8. PubMed ID: 2661139
    [No Abstract]   [Full Text] [Related]  

  • 31. Eicosanoids in asthma, allergic inflammation, and host defense.
    Boyce JA
    Curr Mol Med; 2008 Aug; 8(5):335-49. PubMed ID: 18691060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eosinophil recruitment and activation: the role of lipid mediators.
    Luna-Gomes T; Bozza PT; Bandeira-Melo C
    Front Pharmacol; 2013; 4():27. PubMed ID: 23525348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mast cells as effector cells of innate immunity and regulators of adaptive immunity.
    Cardamone C; Parente R; Feo GD; Triggiani M
    Immunol Lett; 2016 Oct; 178():10-4. PubMed ID: 27393494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in mechanisms of allergic disease in 2016.
    Rothenberg ME; Saito H; Peebles RS
    J Allergy Clin Immunol; 2017 Dec; 140(6):1622-1631. PubMed ID: 29038009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic functional defects of type 2 innate lymphoid cells impair innate allergic inflammation in promyelocytic leukemia zinc finger (PLZF)-deficient mice.
    Verhoef PA; Constantinides MG; McDonald BD; Urban JF; Sperling AI; Bendelac A
    J Allergy Clin Immunol; 2016 Feb; 137(2):591-600.e1. PubMed ID: 26602165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid mediators as regulators of human ILC2 function in allergic diseases.
    Konya V; Mjösberg J
    Immunol Lett; 2016 Nov; 179():36-42. PubMed ID: 27396531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Group 2 innate lymphoid cells and asthma.
    Kabata H; Moro K; Koyasu S; Asano K
    Allergol Int; 2015 Jul; 64(3):227-34. PubMed ID: 26117253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.
    Schwartz C; O'Grady K; Lavelle EC; Fallon PG
    Eur J Immunol; 2016 May; 46(5):1091-100. PubMed ID: 27000936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
    Rubin P; Mollison KW
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):188-97. PubMed ID: 17481554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia.
    Liu B; Lee JB; Chen CY; Hershey GK; Wang YH
    J Immunol; 2015 Apr; 194(8):3583-93. PubMed ID: 25780046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.